Madryn Asset Management, LP Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001787423

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltBuy & Hold how tags are computed

Q2 2026 · 2 positions · Total reported value $36.92M · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 0.0% · 0 new · 0 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, Madryn Asset Management, LP disclosed 2 equity positions with a combined reported value of $36.92M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / Buy & Hold.

The largest disclosed positions as of Q2 2026 were STIM ($24.10M), OMDA ($12.81M). By sector, the heaviest allocations are Health Care 100.0%.

Versus the prior quarter, Madryn Asset Management, LP opened 0 new positions, trimmed 0 and fully exited 0, a turnover rate of 0.0% of positions. The portfolio's overlap with the prior quarter was 100% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

Insider Transactions (Form 4)

Latest Madryn Asset Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-06-15 J Neuronetics, Inc. 4,634 — SEC filing
2026-06-15 J Neuronetics, Inc. 34,932 — SEC filing
2026-06-15 J Neuronetics, Inc. 2,934 — SEC filing
2026-05-28 J Neuronetics, Inc. 3,271 — SEC filing
2026-05-28 J Neuronetics, Inc. 24,658 — SEC filing
2026-05-28 J Neuronetics, Inc. 2,071 — SEC filing

All insider transactions →

Fund Profile

Madryn Asset Management, LP, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 2 positions worth $36.92M in total. HoldingsHub carries 3 quarters of its filings (Q4 2025–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-108769 (status: Approved), registered 2017-01-03
  • Regulatory AUM (Form ADV): $816.17M as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 6 private funds

Portfolio Structure

  • 2 positions · $36.92M reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: STIM (NEURONETICS INC) at 65.3%
  • Average position size: $18.46M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund maintained a conservative stance in Q2 2026, with no new positions and a slight increase in the existing positions. This suggests a preference for stability and a cautious approach to market movements. 2. Key Moves: - No New Positions: The fund did not initiate any new investments, indicating a focus on existing holdings. - Hold Strategy: Both positions were held steady, with no changes in share count or weight. This indicates a belief in the long-term potential of these companies. 3. Portfolio Structure: - Passive vs. Active: The portfolio appears to be passive in nature, as there were no changes in the holdings or strategy. - Sector Bias: The holdings are in the Health Care sector, reflecting a sector-specific focus. - Risk Appetite: The conservative approach and lack of new positions suggest a lower risk appetite. 4. Per-Holding One-Liner: - STIM (NEURONETICS INC): A biotechnology company focusing on developing treatments for neurological disorders. 'Unverified' - OMDA (OMADA HEALTH INC COM): A digital health company offering personalized chronic disease management solutions. 'Unverified' 5. One-Sentence Style Summary: Madryn Asset Management maintained a conservative, sector-specific approach in Q2 2026, holding steady in their existing Health Care investments without taking on new risks or opportunities.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 100.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 18.54M $24.10M 65.29%
65.29%
Hold
2 583.80K $12.81M 34.71%
34.71%
Hold

FAQ

What did Madryn Asset Management, LP buy in 2026-Q2?

In its 2026-Q2 13F filing, Madryn Asset Management, LP reported 2 equity positions worth $36.92M in aggregate; its largest disclosed positions were STIM ($24.10M), OMDA ($12.81M).

How large is Madryn Asset Management, LP's portfolio?

Madryn Asset Management, LP reported $36.92M of long equity holdings across 2 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is Madryn Asset Management, LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / Buy & Hold, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/madryn-asset-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →